Periorificial dermatitis in children and adolescents - 09/08/11
Reprint requests: Lawrence F. Eichenfield, MD, Children’s Hospital and Health Center, Pediatric and Adolescent Dermatology, 8010 Frost St, Suite 602, San Diego, CA 92123.San Diego and San Jose, California
Abstract |
Background |
There has been very little evaluation of the history, morphology, or disease course of perioral/periorificial dermatitis in children.
Objective |
We sought to elucidate the clinical manifestations and treatment outcomes in this condition.
Methods |
A retrospective chart review with telephone follow-up was used to study 79 children and adolescents.
Results |
Patients ranged from 6 months to 18 years of age. The average duration of the rash at presentation was 8 months. Seventy-two percent had a history of topical, inhaled, or systemic steroid exposure. Seventy percent of patients had perioral involvement, 43% perinasal, and 25% periocular involvement. A perivulvar rash was reported in 1% of patients. Treatment with topical metronidazole was associated with clearing on follow-up examination.
Limitations |
This is a retrospective study without case controls and is subject to interviewer and memory bias.
Conclusion |
Perioral dermatitis appears at all ages in childhood and adolescence and may be associated with topical corticosteroid use. It may be responsive to topical metronidazole in children and adolescents and is more appropriately termed periorificial dermatitis.
Il testo completo di questo articolo è disponibile in PDF.Mappa
| Funding sources: None. Conflicts of interest: None identified. |
Vol 55 - N° 5
P. 781-785 - novembre 2006 Ritorno al numero
Articolo precedente
- Instrumental assessment of atopic eczema: Validation of transepidermal water loss, stratum corneum hydration, erythema, scaling, and edema
- Elisabeth A. Holm, Hans C. Wulf, Lars Thomassen, Gregor B.E. Jemec
- Cholesterol embolism: Still an unrecognized entity with a high mortality rate
- Anna Jucgla, Francesc Moreso, Cristina Muniesa, Abelardo Moreno, Antonio Vidaller
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?